BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 19009014)

  • 1. Chronic lymphocytic leukemia cells recognize conserved epitopes associated with apoptosis and oxidation.
    Catera R; Silverman GJ; Hatzi K; Seiler T; Didier S; Zhang L; Hervé M; Meffre E; Oscier DG; Vlassara H; Scofield RH; Chen Y; Allen SL; Kolitz J; Rai KR; Chu CC; Chiorazzi N
    Mol Med; 2008; 14(11-12):665-74. PubMed ID: 19009014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of structurally defined epitopes recognized by monoclonal antibodies produced by chronic lymphocytic leukemia B cells.
    Seiler T; Woelfle M; Yancopoulos S; Catera R; Li W; Hatzi K; Moreno C; Torres M; Paul S; Dohner H; Stilgenbauer S; Kaufman MS; Kolitz JE; Allen SL; Rai KR; Chu CC; Chiorazzi N
    Blood; 2009 Oct; 114(17):3615-24. PubMed ID: 19690339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Many chronic lymphocytic leukemia antibodies recognize apoptotic cells with exposed nonmuscle myosin heavy chain IIA: implications for patient outcome and cell of origin.
    Chu CC; Catera R; Zhang L; Didier S; Agagnina BM; Damle RN; Kaufman MS; Kolitz JE; Allen SL; Rai KR; Chiorazzi N
    Blood; 2010 May; 115(19):3907-15. PubMed ID: 20110421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgG+, CD5+ human chronic lymphocytic leukemia B cells. Production of IgG antibodies that exhibit diminished autoreactivity and IgG subclass skewing.
    Wakai M; Hashimoto S; Omata M; Sthoeger ZM; Allen SL; Lichtman SM; Schulman P; Vinciguerra VP; Diamond B; Dono M
    Autoimmunity; 1994; 19(1):39-48. PubMed ID: 7538331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The
    Perez-Chacon G; Zapata JM
    Front Immunol; 2021; 12():627602. PubMed ID: 33912159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unmutated and mutated chronic lymphocytic leukemias derive from self-reactive B cell precursors despite expressing different antibody reactivity.
    Hervé M; Xu K; Ng YS; Wardemann H; Albesiano E; Messmer BT; Chiorazzi N; Meffre E
    J Clin Invest; 2005 Jun; 115(6):1636-43. PubMed ID: 15902303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibodies against ROR1 induce apoptosis of chronic lymphocytic leukemia (CLL) cells.
    Daneshmanesh AH; Hojjat-Farsangi M; Khan AS; Jeddi-Tehrani M; Akhondi MM; Bayat AA; Ghods R; Mahmoudi AR; Hadavi R; Österborg A; Shokri F; Rabbani H; Mellstedt H
    Leukemia; 2012 Jun; 26(6):1348-55. PubMed ID: 22289919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IGHV1-69-encoded antibodies expressed in chronic lymphocytic leukemia react with malondialdehyde-acetaldehyde adduct, an immunodominant oxidation-specific epitope.
    Que X; Widhopf GF; Amir S; Hartvigsen K; Hansen LF; Woelkers D; Tsimikas S; Binder CJ; Kipps TJ; Witztum JL
    PLoS One; 2013; 8(6):e65203. PubMed ID: 23840319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational status and gene repertoire of IGHV-IGHD-IGHJ rearrangements in Serbian patients with chronic lymphocytic leukemia.
    Karan-Djurasevic T; Palibrk V; Kostic T; Spasovski V; Nikcevic G; Srzentic S; Colovic M; Colovic N; Vidovic A; Antic D; Mihaljevic B; Pavlovic S; Tosic N
    Clin Lymphoma Myeloma Leuk; 2012 Aug; 12(4):252-60. PubMed ID: 22560084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new perspective: molecular motifs on oxidized LDL, apoptotic cells, and bacteria are targets for chronic lymphocytic leukemia antibodies.
    Lanemo Myhrinder A; Hellqvist E; Sidorova E; Söderberg A; Baxendale H; Dahle C; Willander K; Tobin G; Bäckman E; Söderberg O; Rosenquist R; Hörkkö S; Rosén A
    Blood; 2008 Apr; 111(7):3838-48. PubMed ID: 18223168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From normal to clonal B cells: Chronic lymphocytic leukemia (CLL) at the crossroad between neoplasia and autoimmunity.
    Ghia P; Scielzo C; Frenquelli M; Muzio M; Caligaris-Cappio F
    Autoimmun Rev; 2007 Dec; 7(2):127-31. PubMed ID: 18035322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural aspects of human IgM antibodies expressed in chronic B lymphocytic leukemia.
    Ramsland PA; Brock CR; Moses J; Robinson BG; Edmundson AB; Raison RL
    Immunotechnology; 1999 Mar; 4(3-4):217-29. PubMed ID: 10231091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological aspects in chronic lymphocytic leukemia (CLL) development.
    García-Muñoz R; Roldan Galiacho V; Llorente L
    Ann Hematol; 2012 Jul; 91(7):981-96. PubMed ID: 22526361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgM expressed by leukemic CD5(+) B cells binds mouse immunoglobulin light chain.
    Weston KM; Tangye SG; Dunn RD; Smith A; Morris MB; Raison RL
    J Mol Recognit; 2001; 14(4):245-53. PubMed ID: 11500971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced outgrowth of EBV-transformed chronic lymphocytic leukemia B cells mediated by coculture with macrophage feeder cells.
    Hwang KK; Chen X; Kozink DM; Gustilo M; Marshall DJ; Whitesides JF; Liao HX; Catera R; Chu CC; Yan XJ; Luftig MA; Haynes BF; Chiorazzi N
    Blood; 2012 Feb; 119(7):e35-44. PubMed ID: 22160618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of autoantibodies by CD5-expressing B lymphocytes from patients with chronic lymphocytic leukemia.
    Sthoeger ZM; Wakai M; Tse DB; Vinciguerra VP; Allen SL; Budman DR; Lichtman SM; Schulman P; Weiselberg LR; Chiorazzi N
    J Exp Med; 1989 Jan; 169(1):255-68. PubMed ID: 2462608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of two anti-CD5 monoclonal antibodies synergistically induces complement-dependent cytotoxicity of chronic lymphocytic leukaemia cells.
    Klitgaard JL; Koefoed K; Geisler C; Gadeberg OV; Frank DA; Petersen J; Jurlander J; Pedersen MW
    Br J Haematol; 2013 Oct; 163(2):182-93. PubMed ID: 23927424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Broad alterations of self-reactive antibody-repertoires of plasma IgM and IgG in B-cell chronic lymphocytic leukemia (B-CLL) and B-CLL related target-restricted autoimmunity.
    Stahl D; Lacroix-Desmazes S; Sibrowski W; Kazatchkine MD; Kaveri SV
    Leuk Lymphoma; 2001 Jun; 42(1-2):163-76. PubMed ID: 11699204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogen-specific B-cell receptors drive chronic lymphocytic leukemia by light-chain-dependent cross-reaction with autoantigens.
    Jiménez de Oya N; De Giovanni M; Fioravanti J; Übelhart R; Di Lucia P; Fiocchi A; Iacovelli S; Efremov DG; Caligaris-Cappio F; Jumaa H; Ghia P; Guidotti LG; Iannacone M
    EMBO Mol Med; 2017 Nov; 9(11):1482-1490. PubMed ID: 28899929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic lymphocytic leukemia antibodies with a common stereotypic rearrangement recognize nonmuscle myosin heavy chain IIA.
    Chu CC; Catera R; Hatzi K; Yan XJ; Zhang L; Wang XB; Fales HM; Allen SL; Kolitz JE; Rai KR; Chiorazzi N
    Blood; 2008 Dec; 112(13):5122-9. PubMed ID: 18812466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.